Arcutis Biotherapeutics, Inc. entered into a License Agreement with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. for the development and commercialization of certain dermatological products in Greater China and Southeast Asia, with upfront and milestone payments.